Anaveon AG

Anaveon AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://www.anaveon.com

A Study Evaluating ANV600 Single Agent or in Combination with Pembrolizumab in Participants with Advanced Solid Tumors (EXPAND-1)

First Posted Date
2024-06-24
Last Posted Date
2024-11-08
Lead Sponsor
Anaveon AG
Target Recruit Count
240
Registration Number
NCT06470763
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

🇫🇷

Institut Bergonie, Bordeaux, France

🇩🇪

Krankenhaus Nordwest - Institut für Klinisch-Onkologische Forschung (IKF), Frankfurt, Germany

and more 12 locations

A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)

First Posted Date
2022-12-07
Last Posted Date
2024-02-12
Lead Sponsor
Anaveon AG
Target Recruit Count
4
Registration Number
NCT05641324
Locations
🇩🇰

Vejle Hospital, Vejle, Denmark

🇫🇷

CHU de Nantes - Hôtel-Dieu, Nantes, France

🇫🇷

Institut Paoli-Calmettes, Marseille, France

and more 8 locations

A Study of ANV419 Alone or in Combination with Approved Treatment in Patients with Cutaneous Melanoma (OMNIA-1).

First Posted Date
2022-10-13
Last Posted Date
2024-11-27
Lead Sponsor
Anaveon AG
Target Recruit Count
29
Registration Number
NCT05578872
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

University of California San Diego, La Jolla, California, United States

🇺🇸

University of California San Francisco, San Francisco, California, United States

and more 22 locations

A Study Evaluating Safety and Therapeutic Activity of ANV419 in Patients with Advanced Cancer.

First Posted Date
2021-04-22
Last Posted Date
2024-11-08
Lead Sponsor
Anaveon AG
Target Recruit Count
55
Registration Number
NCT04855929
Locations
🇪🇸

Hospital Vall d'Hebrón, Barcelona, Spain

🇪🇸

START Madrid, Hospital Universitario HM Sanchinarro, Madrid, Spain

🇨🇭

University Hospital Basel, Basel, Switzerland

and more 2 locations
© Copyright 2024. All Rights Reserved by MedPath